- Daaweyn
- Markhaatiyada
- Neuroblastoma
- Buro adag
- Markhaatiyada
- TILS
- Daaweynta Unugyada NK
- Myasthenia Gravis (MG)
- Leukemia-da Lymphoblastic ee Ba'an (B-ALL)
- Lupus Erythematosus oo nidaamsan (SLE)
- Leukemia-da Lymphoblastic ee Ba'an (T-ALL)
- Lymphoma-ka aan Hodgkin ahayn (NHL)
- Myeloma badan (MM)
- Lymphom-ka Unugga B-B ee Kala-baxa
- Leukemia-da B-lymphocytic
- Myeloma
Kansarka naasaha bidix oo ay weheliso metastasis badan oo lafo ah (Marxaladda IV), metastasis qanjidhada lymph node, iyo kansarka lymphangitis ee labada sambabood-03
Bishii Maajo 2014, Ms. W waxaa lagu ogaaday kansarka naasaha bidix oo ay weheliso metastases badan oo lafo ah (Marxaladda IV), metastasis qanjidhada lymph node, iyo kansarka lymphangitis ee labada sambab, iyo dhibaatooyin kale.
Iyadoo dhakhtarkeedu talo ahaan u soo jeediyay, Ms. W waxay qaadatay daawaynta kiimoterabiga si ay u baabi'iso unugyada kansarka ee ugu badan intii suurtogal ah. Ka dib, waxay qaadatay steroids iyo daawooyinka xanuunka baabi'iya, laakiin unugyada kansarku way sii yaraanayeen, dhakhaatiirtuna waxay ku qiyaaseen inay noolaan karto wax ka badan saddex bilood.
Markii dambe, saaxiib ku takhasusay caafimaadka ayaa qoyska Ms. W u sheegay in daaweynta dhaqameed ee kansarka naasaha ee Shiinaha ay leedahay heerka badbaadada shan sano oo ah 73.1%, halka daaweynta difaaca jirka ama isku darka daaweynta difaaca jirka iyo daaweynta dhaqameed ay leedahay heerka badbaadada shan sano oo ah 95%. Tani waxay siisay Ms. W rajo yar.
Marwo W iyo qoyskeedu waxay ogaadeen daaweynta difaaca jirka ee laga heli karo Jaamacadda Caafimaadka ee Nanjing waxayna go'aansadeen inay sii wadaan. Kooxda caafimaadku waxay markii ugu horreysay ee ay isku shaandheeyaan burooyinka Ms. W waxayna xaqiijiyeen xaaladda unugyada difaaca jirka iyada oo loo marayo baaritaanno shaqada difaaca jirka. Dabadeed, waxay bilaabeen daaweynta difaaca jirka. Si mucjiso ah, afar bilood ka dib, neefta oo yaraatay Ms. W si weyn ayay u soo hagaagtay. Lix bilood ka dib daaweynta, xanuunkeedu si wax ku ool ah ayuu u yaraaday, uma baahnayn inay la noolaato haan oksijiin ah, waxayna joojin kartay qaadashada daawooyinka xanuunka baabi'iya iyo steroids. Hal sano ka dib, sawir-qaadista dabagalka (PET/CT) waxay muujisay hoos u dhac weyn oo ku yimid unugyada kansarka marka la barbar dhigo daaweynta ka hor. (Sawirrada soo socda waxay muujinayaan sawirka daaweynta ka hor ee bidixda iyo sawirka daaweynta ka dib ee midig.)
Maanta, Ms. W kama maqna wax nabarro kansar ah waxayna awood u leedahay inay ku noolaato nolol caadi ah.
sharraxaad2

